Silence Therapeutics (SLN) Change in Cash (2020 - 2026)

Silence Therapeutics' Change in Cash history runs 7 years deep, the most recent figure standing at -$5.6 million for Q1 2026.

• In Q1 2026, Change in Cash rose 90.11% year-over-year to -$5.6 million; the TTM figure through Mar 2026 stood at -$59.2 million (up 23.85% YoY), while the FY2025 annual figure was -$110.2 million, down 310.07% from the prior year.
• Change in Cash came in at -$5.6 million for Q1 2026 at Silence Therapeutics, up from -$70.6 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $74.0 million in Q1 2024 to a low of -$70.6 million in Q4 2025.
• A 5-year average of -$5.0 million and a median of -$9.1 million in 2023 frame the typical range for Change in Cash.
• On a YoY basis, Change in Cash climbed as much as 16706.5% in 2022 and fell as far as 1253.11% in 2022.
• Silence Therapeutics' Change in Cash stood at -$34.9 million in 2022, then surged by 94.44% to -$1.9 million in 2023, then soared by 2085.72% to $38.5 million in 2024, then tumbled by 283.22% to -$70.6 million in 2025, then soared by 92.07% to -$5.6 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$5.6 million, -$70.6 million, and $40.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison